Company Profiles

driven by the PitchBook Platform

Angstrom Pharmaceuticals

Description

Developer of pharmaceutical drugs designed to treat metastatic diseases and hematological malignancies. The company's pharmaceutical drugs offer a CD44 binding peptide in clinical development for treatment of ovarian cancer and chronic lymphocytic leukemia, enabling patients with cancer, diabetic retinopathy and age-related macular degeneration to get improved clinical treatment.

1996

Founded

OOB

Status

1-10

Employees

Out of Business

Latest Deal Type

$14.8M

Total Amount Raised

Description

Developer of pharmaceutical drugs designed to treat metastatic diseases and hematological malignancies. The company's pharmaceutical drugs offer a CD44 binding peptide in clinical development for treatment of ovarian cancer and chronic lymphocytic leukemia, enabling patients with cancer, diabetic retinopathy and age-related macular degeneration to get improved clinical treatment.

Website:

www.angstrominc.com

Ownership Status

Out of Business

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

990 Highland Drive Suite 110V Solana Beach, CA 92075United States +1 (858) 314-2356
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Angstrom Pharmaceuticals's full profile, request a free trial.

    Angstrom Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Angstrom Pharmaceuticals Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Malcolm Finlayson Ph.DChief Executive Officer & President
    Dale KostmanChief Financial Officer
    Terence Jones Ph.DFounder & Chief Technology Officer
    Virgil Thompson Ph.DAdvisor
    Malcolm Finlayson Ph.D Chief Executive Officer & President
    Dale Kostman Chief Financial Officer
    Terence Jones Ph.D Founder & Chief Technology Officer
    Virgil Thompson Ph.D Advisor

    Angstrom Pharmaceuticals Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Chi YapSelfBoard Member000 0000
    David U'Prichard Ph.DSelfBoard Member000 0000
    Martin NashSelfBoard Member000 0000
    Stephen Howell MDSelfBoard Member000 0000
    Chi Yap Board Member Self
    David U'Prichard Ph.D Board Member Self
    Martin Nash Board Member Self
    Stephen Howell MD Board Member Self
    Request full access to PitchBook